Cargando…

Global epidemiology of campylobacteriosis and the impact of COVID-19

Campylobacteriosis is a gastroenteritis caused by pathogenic Campylobacter species and an important topic in public health. Here we review the global epidemiology of campylobacteriosis in the last eight years between 2014-2021, providing comprehensive and updated information on the reported incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Lee, Seul A., Xue, Jessica, Riordan, Stephen M., Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742372/
https://www.ncbi.nlm.nih.gov/pubmed/36519137
http://dx.doi.org/10.3389/fcimb.2022.979055
_version_ 1784848501161590784
author Liu, Fang
Lee, Seul A.
Xue, Jessica
Riordan, Stephen M.
Zhang, Li
author_facet Liu, Fang
Lee, Seul A.
Xue, Jessica
Riordan, Stephen M.
Zhang, Li
author_sort Liu, Fang
collection PubMed
description Campylobacteriosis is a gastroenteritis caused by pathogenic Campylobacter species and an important topic in public health. Here we review the global epidemiology of campylobacteriosis in the last eight years between 2014-2021, providing comprehensive and updated information on the reported incidence and outbreaks of Campylobacter infections. The government public health website of each of the 195 countries and publications from 2014 to September 2022 in public databases were searched. The reported incidence of campylobacteriosis in pre-COVID-19 years was compared to that during the COVID-19 pandemic in countries where data were available. Czech Republic had the highest reported incidence of campylobacteriosis worldwide (215 per 100,000 in 2019), followed by Australia (146.8 per 100,000 in 2016) and New Zealand (126.1 per 100,000 in 2019). Campylobacter was one of the most common human enteric pathogens in both developed and developing countries. About 90% of cases of campylobacteriosis were caused by Campylobacter jejuni, whereas less than 10% of cases were caused by Campylobacter coli. Other Campylobacter species were also isolated. The reported incidence and case numbers of campylobacteriosis in developed nations have remained steadily high prior to the COVID-19 pandemic, whilst some countries reported an increasing trend such as France and Japan. While outbreaks were more frequently reported in some countries, Campylobacter infections were mainly sporadic cases in most of the developed countries. Campylobacter infection was more common in summer in some but not all countries. Campylobacter infection was more common in males than females. The COVID-19 pandemic has reduced the reported incidence of campylobacteriosis in most countries where 2020 epidemiology data were available. In conclusion, Campylobacter infection remains a global health concern. Increased research and improved strategies are needed for prevention and reduction of Campylobacter infection.
format Online
Article
Text
id pubmed-9742372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97423722022-12-13 Global epidemiology of campylobacteriosis and the impact of COVID-19 Liu, Fang Lee, Seul A. Xue, Jessica Riordan, Stephen M. Zhang, Li Front Cell Infect Microbiol Cellular and Infection Microbiology Campylobacteriosis is a gastroenteritis caused by pathogenic Campylobacter species and an important topic in public health. Here we review the global epidemiology of campylobacteriosis in the last eight years between 2014-2021, providing comprehensive and updated information on the reported incidence and outbreaks of Campylobacter infections. The government public health website of each of the 195 countries and publications from 2014 to September 2022 in public databases were searched. The reported incidence of campylobacteriosis in pre-COVID-19 years was compared to that during the COVID-19 pandemic in countries where data were available. Czech Republic had the highest reported incidence of campylobacteriosis worldwide (215 per 100,000 in 2019), followed by Australia (146.8 per 100,000 in 2016) and New Zealand (126.1 per 100,000 in 2019). Campylobacter was one of the most common human enteric pathogens in both developed and developing countries. About 90% of cases of campylobacteriosis were caused by Campylobacter jejuni, whereas less than 10% of cases were caused by Campylobacter coli. Other Campylobacter species were also isolated. The reported incidence and case numbers of campylobacteriosis in developed nations have remained steadily high prior to the COVID-19 pandemic, whilst some countries reported an increasing trend such as France and Japan. While outbreaks were more frequently reported in some countries, Campylobacter infections were mainly sporadic cases in most of the developed countries. Campylobacter infection was more common in summer in some but not all countries. Campylobacter infection was more common in males than females. The COVID-19 pandemic has reduced the reported incidence of campylobacteriosis in most countries where 2020 epidemiology data were available. In conclusion, Campylobacter infection remains a global health concern. Increased research and improved strategies are needed for prevention and reduction of Campylobacter infection. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9742372/ /pubmed/36519137 http://dx.doi.org/10.3389/fcimb.2022.979055 Text en Copyright © 2022 Liu, Lee, Xue, Riordan and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Liu, Fang
Lee, Seul A.
Xue, Jessica
Riordan, Stephen M.
Zhang, Li
Global epidemiology of campylobacteriosis and the impact of COVID-19
title Global epidemiology of campylobacteriosis and the impact of COVID-19
title_full Global epidemiology of campylobacteriosis and the impact of COVID-19
title_fullStr Global epidemiology of campylobacteriosis and the impact of COVID-19
title_full_unstemmed Global epidemiology of campylobacteriosis and the impact of COVID-19
title_short Global epidemiology of campylobacteriosis and the impact of COVID-19
title_sort global epidemiology of campylobacteriosis and the impact of covid-19
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742372/
https://www.ncbi.nlm.nih.gov/pubmed/36519137
http://dx.doi.org/10.3389/fcimb.2022.979055
work_keys_str_mv AT liufang globalepidemiologyofcampylobacteriosisandtheimpactofcovid19
AT leeseula globalepidemiologyofcampylobacteriosisandtheimpactofcovid19
AT xuejessica globalepidemiologyofcampylobacteriosisandtheimpactofcovid19
AT riordanstephenm globalepidemiologyofcampylobacteriosisandtheimpactofcovid19
AT zhangli globalepidemiologyofcampylobacteriosisandtheimpactofcovid19